EDESA BIOTECH, INC. Common Stock, Capital Shares Reserved for Future Issuance
EDESA BIOTECH, INC. (EDSA) had Common Stock, Capital Shares Reserved for Future Issuance of 142.86 thousand shares as of 2018-09-30, per its 10-K filed 2018-11-30.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2018-11-30
- 2018-09-30: Common Stock, Capital Shares Reserved for Future Issuance 142.86K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2018-09-30 | 142.86K shares 10-K · filed 2018-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |